Patent Assignment
Reel/Frame 074509/0552
Release of Security Interest
Recorded: 2026-04-29
Pages: 6
Assignor
OHA AGENCY LLC, IN ITS CAPACITY AS ADMINISTRATIVE AGENT
Executed: 2026-04-16
Assignee
EMERGENT BIOSOLUTIONS CANADA INC.
155 INNOVATION DRIVE, WINNIPEG, R3T 5Y3, CANADA
Covered Properties
(3)
Hyperimmune Globulin Formulations
Application:
18/246,373 →
Publication:
US 2024/0052020
Antimicrobial Compositions Comprising a Hyaluronic Acid Binding Peptide and a Beta-Lactam Antibiotic
Antibodies Against Clostridium Difficile
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Mar 16, 2017
From: CANGENE CORPORATION
To: EMERGENT BIOSOLUTIONS CANADA INC.
Reel/Frame 041591/0382 →
Assignment of Assignor's Interest
May 18, 2018
From: NYKIFORUK, CORY
To: EMERGENT BIOSOLUTIONS CANADA INC.
Reel/Frame 045845/0217 →
Assignment of Assignor's Interest
May 18, 2018
From: JOHNSTONE, DARRELL; GEORGE, JOYEE ANTONY; BERRY, JODY
To: CNJ HOLDINGS INC.
Reel/Frame 045845/0139 →
Merger
May 29, 2018
From: CNJ HOLDINGS INC.; CANGENE CORPORATION
To: CANGENE CORPORATION
Reel/Frame 045920/0482 →
Merger and Change of Name
May 29, 2018
From: CANGENE CORPORATION; EMERGENT PROTECTIVE PRODUCTS CANADA INC.; EMERGENT BIOSOLUTIONS CANADA INC.
To: EMERGENT BIOSOLUTIONS CANADA INC.
Reel/Frame 045920/0540 →
Merger
Jun 21, 2018
From: CANGENE CORPORATION; CNJ HOLDINGS INC.
To: CANGENE CORPORATION
Reel/Frame 046154/0867 →
Notice of Grant of Security Interest in U.S. Patents
Sep 3, 2024
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT BIOSOLUTIONS CANADA INC.; EMERGENT BIOSOLUTIONS INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC
To: OHA AGENCY LLC
Reel/Frame 068828/0233 →
Security Interest
Sep 30, 2024
From: EMERGENT BIODEFENSE OPERATIONS LANSING LLC; EMERGENT BIOSOLUTIONS INC.; EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.; EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 068746/0698 →
Security Interest
Apr 16, 2026
From: EMERGENT BIOSOLUTIONS CANADA INC.
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP, AS ADMINISTRAT
Reel/Frame 074388/0924 →